Curemark, LLC
Records under this name other than the patents Curemark, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 33 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,776,453 | Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,084,784 | Compositions and methods for the treatment or the prevention of E. coli infections and for the eradication or reduction of E. coli surfaces Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,107,419 | Compositions and Methods for Treatment or Prevention of Staphylococcus Aureus Infections and for the Eradication or Reduction of Staphylococcus Aureus on Surfaces Formerly held In force · High confidence | In force | High confidence | |
| US 8,673,877 | Use of lactulose in the treatment of autism Term ended Term ended Aug 30, 2026 · From the USPTO record | Term ended | Term ended Aug 30, 2026 | From the USPTO record |
| US 9,345,721 | Use of lactulose in the treatment of autism Term ended Ended no later than Aug 30, 2026 · From the USPTO record | Term ended | Ended no later than Aug 30, 2026 | From the USPTO record |
| US 10,350,229 | Use of lactulose in the treatment of autism Term ended Ended no later than Aug 30, 2026 · From the USPTO record | Term ended | Ended no later than Aug 30, 2026 | From the USPTO record |
| US 11,033,563 | Use of lactulose in the treatment of autism Term ended Ended no later than Aug 30, 2026 · From the USPTO record | Term ended | Ended no later than Aug 30, 2026 | From the USPTO record |
| US 10,413,601 | Methods and compositions for the treatment of symptoms of prion diseases Lapsed on the fee record Ended Sep 17, 2023 · From the USPTO record | Lapsed on the fee record | Ended Sep 17, 2023 | From the USPTO record |
| US 9,061,033 | Methods and compositions for the treatment of symptoms of prion diseases Lapsed on the fee record Ended Jun 23, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jun 23, 2023 | From the USPTO record |
| US 8,030,002 | Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions Term ended Term ended Nov 16, 2021 · From the USPTO record | Term ended | Term ended Nov 16, 2021 | From the USPTO record |